Table of Contents
Journal of Vaccines
Volume 2013 (2013), Article ID 212367, 13 pages
http://dx.doi.org/10.1155/2013/212367
Research Article

Comparison of Oral Tolerance to ApoB and HSP60 Peptides in Preventing Atherosclerosis Lesion Formation in Apob48/Ldlr Mice

1Mary and Gary Western and Tata Molecular Immunology Unit, Thrombosis Research Institute, Bangalore, Karnataka 560099, India
2Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam 784028, India
3Molecular Immunology Unit, Thrombosis Research Institute, London SW3 6LR, UK

Received 31 October 2012; Accepted 17 December 2012

Academic Editor: Barbara Schnierle

Copyright © 2013 Lakshmi Mundkur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Baigent, A. Keech, P. M. Kearney et al., “Efficacy and safety of cholesterollowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins,” Lancet, vol. 366, no. 9493, pp. 1267–1278, 2005. View at Google Scholar
  2. J. Andersson, P. Libby, and G. K. Hansson, “Adaptive immunity and atherosclerosis,” Clinical Immunology, vol. 134, no. 1, pp. 33–46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. G. K. Hansson, “Immune mechanisms in atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, pp. 1876–1890, 2001. View at Google Scholar
  4. G. K. Hansson, “Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease,” New England Journal of Medicine, vol. 352, no. 16, pp. 1685–1626, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Sakaguchi, “Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self,” Nature Immunology, vol. 6, no. 4, pp. 345–352, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. H. von Boehmer, “Mechanisms of suppression by suppressor T cells,” Nature Immunology, vol. 6, no. 4, pp. 338–344, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Mallat and A. Tedgui, “Immunomodulation to combat atherosclerosis: the potential role of immune regulatory cells,” Expert Opinion on Biological Therapy, vol. 4, no. 9, pp. 1387–1393, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. G. K. Hansson, “Atherosclerosis—an immune disease. The anitschkov lecture 2007,” Atherosclerosis, vol. 202, no. 1, pp. 2–10, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Mallat, H. Ait-Oufella, and A. Tedgui, “Regulatory T-cell immunity in atherosclerosis,” Trends in Cardiovascular Medicine, vol. 17, no. 4, pp. 113–118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. G. K. Hansson and J. Nilsson, “Vaccination against atherosclerosis? Induction of atheroprotective immunity,” Seminars in Immunopathology, vol. 31, no. 1, pp. 95–101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. L. A. Mundkur and V. V. Kakkar, “Immune modulation as a therapeutic strategy for atherosclerosis,” Current Drug Therapy, vol. 5, no. 4, pp. 288–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Nilsson, G. N. Fredrikson, H. Björkbacka, K. Y. Chyu, and P. K. Shah, “Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease,” Journal of Internal Medicine, vol. 266, no. 3, pp. 221–231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ameli, A. Hultgårdh-Nilsson, J. Regnström et al., “Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 8, pp. 1074–1079, 1996. View at Google Scholar · View at Scopus
  14. C. J. Binder, S. Hörkkö, A. Dewan et al., “Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL,” Nature Medicine, vol. 9, no. 6, pp. 736–743, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Palinski, E. Miller, and J. L. Witztum, “Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 3, pp. 821–825, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Zhou, G. Caligiuri, A. Hamsten, A. K. Lefvert, and G. K. Hansson, “LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 1, pp. 108–114, 2001. View at Google Scholar · View at Scopus
  17. R. V. Farese Jr., M. M. Véniant, C. M. Cham et al., “Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 13, pp. 6393–6398, 1996. View at Google Scholar
  18. S. A. Ahmed, R. M. Gogal Jr., and J. E. Walsh, “A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay,” Journal of Immunological Methods, vol. 170, no. 2, pp. 211–224, 1994. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Maron, G. Sukhova, A. M. Faria et al., “Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice,” Circulation, vol. 106, no. 13, pp. 1708–1715, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. G. H. M. van Puijvelde, A. D. Hauer, P. de Vos et al., “Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis,” Circulation, vol. 114, no. 18, pp. 1968–1976, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. George, N. Yacov, E. Breitbart et al., “Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with β2-glycoprotein I,” Cardiovascular Research, vol. 62, no. 3, pp. 603–609, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Ait-Oufella, B. L. Salomon, S. Potteaux et al., “Natural regulatory T cells control the development of atherosclerosis in mice,” Nature Medicine, vol. 12, no. 2, pp. 178–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. H. M. van Puijvelde, T. van Es, E. J. A. van Wanrooij et al., “Induction of oral tolerance to HSP60 or an HSP60-peptide activates t cell regulation and reduces atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 12, pp. 2677–2683, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Sasaki, T. Yamashita, M. Takeda et al., “Oral anti-CD3 antibody treatment induces regulatory t cells and inhibits the development of atherosclerosis in mice,” Circulation, vol. 120, no. 20, pp. 1996–2005, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Klingenberg, M. Lebens, A. Hermansson et al., “Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 5, pp. 946–952, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. G. L. Stephens and E. M. Shevach, “Foxp3+ regulatory T cells: selfishness under scrutiny,” Immunity, vol. 27, no. 3, pp. 417–419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Mallat, S. Taleb, H. Ait-Oufella, and A. Tedgui, “The role of adaptive T cell immunity in atherosclerosis,” Journal of Lipid Research, vol. 50, pp. S364–S369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Mor, D. Planer, G. Luboshits et al., “Role of naturally occurring CD4+CD25+ regulatory T cells in experimental atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 4, pp. 893–900, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Harats, N. Yacov, B. Gilburd, Y. Shoenfeld, and J. George, “Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions,” Journal of the American College of Cardiology, vol. 40, no. 7, pp. 1333–1338, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. D. J. Grainger, “Transforming growth factor β and atherosclerosis: so far, so good for the protective cytokine hypothesis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 3, pp. 399–404, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. A. C. Doran, N. Meller, and C. A. McNamara, “Role of smooth muscle cells in the initiation and early progression of atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 5, pp. 812–819, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. X. Lu, D. Chen, V. Endresz et al., “Immunization with a combination of ApoB and HSP60 epitopes significantly reduces early atherosclerotic lesion in Apobtm2SgyLdlrtm1Her/J mice,” Atherosclerosis, vol. 212, no. 2, pp. 472–480, 2010. View at Publisher · View at Google Scholar · View at Scopus